AMN Healthcare Services, Inc.

As of February 20, 2025, AMN Healthcare Services, Inc. is considered risky and overvalued, with a P/E ratio of 18 compared to a peer average of 20.16, and it has significantly underperformed the market with a -58.84% return over the past year.

As of February 20, 2025, AMN Healthcare Services, Inc. is considered overvalued and risky, with a P/E ratio of 18 compared to the industry average of 20.72, an EV to EBITDA ratio of 6.85, and a one-year return of -60.03%, indicating significant underperformance relative to its peers and the S&P 500.

As of June 6, 2025, AMN Healthcare Services, Inc. shows a mildly bearish trend, with mixed signals from indicators like the MACD, Bollinger Bands, and KST, suggesting a cautious outlook.

As of March 2022, the management team of AMN Healthcare Services, Inc. includes Douglas Wheat (Independent Chairman), Susan Salka (CEO), and several independent directors: Mark Foletta, Teri Fontenot, R. Jeffrey Harris, Michael Johns, and Daphne Jones. They oversee the company's strategic direction and operations.

AMN Healthcare Services, Inc. offers healthcare workforce solutions and staffing services, with a market cap of USD 898.19 million. As of March 2025, it reported net sales of USD 690 million and a net profit of USD -1 million.

As of Jun 18, AMN Healthcare Services, Inc. has a market capitalization of 898.19 million, with net sales of 2,852.43 million and a net profit of -165.39 million over the latest four quarters.